| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |